This content is machine translated Antiphospholipid syndrome Preferably anticoagulate with VKA or heparin Antiphospholipid syndrome (APS) is an acquired thrombophilia and is associated with a high risk of venous, arterial or microvascular thrombosis. In APS with thrombotic manifestations, lifelong anticoagulation is generally indicated.…
View Post 4 min This content is machine translated Pulmonary embolism Anticoagulate hemodynamically unstable patients even on suspicion Patients with pulmonary embolism require anticoagulation for a period of at least three months. Before starting therapy, several considerations must be addressed: Which anticoagulant is the most appropriate for this…
View Post 3 min This content is machine translated Oral anticoagulation New brooms sweep better!? In nonvalvular atrial fibrillation, treatment with oral anticoagulants is indicated. Many guidelines recommend the use of direct oral anticoagulants (DOAK) as first-line therapy. The advantage here is considered to be…
View Post 8 min This content is machine translated Thrombophilia Antiphospholipid syndrome – an update. The systemic autoimmune disease APS (antiphospholipid syndrome) is mainly characterized by thrombotic manifestations. As acquired thrombophilia, variable drug thromboprophylaxis is indicated.
View Post 4 min This content is machine translated Anticoagulation Procedure for special patient groups Continuing postmenopausal hormone therapy or hormone-containing contraception in women on anticoagulation seems risky. After all, hormone-containing preparations increase the risk of venous thromboembolism, which anticoagulants are intended to reduce. But…
View Post 6 min This content is machine translated Mechanical vaccination can save lives Atrial appendage closure in patients with atrial fibrillation More than 95% of all emboli in patients with atrial fibrillation originate in the left atrial ear. Atrial appendage closure can be performed by means of a 20-minute procedure under…
View Post 8 min This content is machine translated Therapy update on atrial fibrillation Important concepts and new paradigms in the treatment of atrial fibrillation. Atrial fibrillation is a dynamic arrhythmia that requires individual and broad investigations and therapeutic approaches. Comprehensive treatment of atrial fibrillation patients is based on five pillars: 1. prevention of thromboembolic…
View Post 6 min This content is machine translated Symposium Interventional Cardiology Too much of a good thing or not enough? The Interventional Cardiology Symposium at the University Hospital Zurich was also dedicated to anticoagulants and antiplatelet agents. Here, the question was “one, two, or three?” As it turned out, the…
View Post 6 min This content is machine translated Medidays: Update Hematology Anemia, new anticoagulants, and CLL. At Medidays, the internal medicine training program of the University Hospital Zurich (USZ), presentations were also given on various hematology topics. How is anemia meaningfully clarified? Which patients should be…
View Post 7 min This content is machine translated Follow-up after heart surgery and intervention Which valve needs to be anticoagulated and how? There is clear evidence for oral anticoagulation in mechanical valves. However, individual adjustments of the target INR are sometimes necessary. Moreover, additional platelet inhibition to OAK is becoming routine. The…
View Post 9 min This content is machine translated New oral anticoagulants 10 questions from daily use The new oral anticoagulants (NOAKs) have long since become part of everyday clinical practice in stroke prophylaxis for atrial fibrillation. Due to their simpler, safer, and effective use, they are…
